Full Professor of Microbiology and Immunology
Proteomics Facility Director
Executive Board Member of the SEASR/Association of Biomolecular Research Facilities
Department of Microbiology and Immunology, School of Medicine, Universidad Central del Caribe, Bayamón, PR.
Email: nawal.boukli@uccaribe.edu
Complete list of publications: www.ncbi.nlm.nih.gov/pubmed/?term=nawal+boukli
Dr. Boukli is a Professor in the department of microbiology and immunology and is the Director of the Biomedical Proteomics Facility at the Universidad Central del Caribe, School of Medicine, PR, USA. Dr. Boukli got her Doctoral degree in Molecular Biology from the University of Geneva, Switzerland, where she worked in early molecular signaling events such as the type three secretion pathway in Rhyzobium bacteria. Dr. Boukli did her postdoctoral fellowship at the University of Missouri where she gained more expertise in proteomics technology and detection of biomarkers. She then joined the Universidad Central Del Caribe where she organized a high-throughput Proteomic Core Facility. Dr. Boukli’s research uses the latest technologies, including quantitative proteomics multiplexing with isobaric tags approaches and molecular and flow cytometric analyses for the detection of biomarkers and molecular signatures in HIV, cancer, drug and alcohol of abuse. Dr. Boukli has numerous peer-review articles and funded grants on these and related topics. Dr. Boukli is also interested in how endoplasmic reticulum stress responses and cell fate decision can regulate the network of apoptotic and survival signal events in different cells and systems and the anti-cancer and anti-HIV mechanistic effects of natural compounds for cancer and HIV treatment. In addition to her research pursuits, Dr. Boukli has been active in training young investigators, both individually (as a mentor and proteomics facility resource, faculty, post-doctoral fellows, medical students, Master and Ph.D. trainees) and in the classroom (where she has developed a proteomics graduate-level course and several workshops on proteomics in clinical research).
(Updated Oct 4, 2023)